George Poste

Chf Scientist & Regent's Prof

Regents' Professor, Life Sciences, School of (SOLS)
Regents' Professor, Innovations in Medicine, Biodesign Center for (IM)
Regents' Professor, Molecular Sciences, School of
Regents' Professor, Personalized Diagnostics, Biodesign Piper Center for (PPD)
Regents' Professor, Bioenergetics, Biodesign Center for (BE)
Chief Scientist, Complex Adaptive Systems (CAS)
Regents' Professor, Biodesign Institute (BDI)
Regents' Professor, Biodesign Institute (BDI)

13063 Citations
61 h-Index

If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

DSc, University of Bristol

… → 1987

PHD, University of Bristol

… → 1969

DVM, University of Bristol

… → 1966

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Cell Fusion Medicine & Life Sciences

Macrophages Medicine & Life Sciences

Neoplasm Metastasis Medicine & Life Sciences

Liposomes Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Cultured Cells Medicine & Life Sciences

Experimental Neoplasms Medicine & Life Sciences

Newcastle disease virus Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1970 2018

13063 Citations
61 h-Index
243 Article
7 Chapter
1 Review article

6 Citations

Adaptive global innovative learning environment for glioblastoma: GBM AGILE

GBM AGILE Network, Feb 15 2018, In : Clinical Cancer Research. 24, 4, p. 737-743 7 p.

Research output: Contribution to journal › Review article

Glioblastoma

Learning

Biomarkers

Therapeutics

Random Allocation

Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes

Domenyuk, V. , Gatalica, Z. , Santhanam, R. , Wei, X. , Stark, A. , Kennedy, P. , Toussaint, B. , Levenberg, S. , Wang, J. , Xiao, N. , Greil, R. , Rinnerthaler, G. , Gampenrieder, S. P. , Heimberger, A. B. , Berry, D. A. , Barker, A. , Quackenbush, J. , Marshall, J. L. , Poste, G. , Vacirca, J. L. & 9 others Vidal, G. A., Schwartzberg, L. S., Halbert, D. D., Voss, A., Magee, D., Miglarese, M. R., Famulok, M., Mayer, G. & Spetzler, D., Dec 1 2018, In : Nature Communications. 9, 1, 1219

Research output: Contribution to journal › Article

ligand

cancer

drug development

tumor

phenotype

1 Citations

Converging and emerging threats to health security

Raina Macintyre, C., Engells, T. E., Scotch, M., Heslop, D. J., Gumel, A. B., Poste, G., Chen, X., Herche, W., Steinhöfel, K., Lim, S. & Broom, A., Nov 27 2017, (Accepted/In press) In : Environment Systems and Decisions. p. 1-10 10 p.

Research output: Contribution to journal › Article

biological weapon

regulatory framework

Cold War

medicine

health care

5 Citations

Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach

Domenyuk, V. , Zhong, Z. , Stark, A. , Xiao, N. , O'Neill, H. A. , Wei, X. , Wang, J. , Tinder, T. T. , Tonapi, S. , Duncan, J. , Hornung, T. , Hunter, A. , Miglarese, M. R. , Schorr, J. , Halbert, D. D. , Quackenbush, J. , Poste, G. , Berry, D. A. , Mayer, G. , Famulok, M. & 1 others Spetzler, D., Feb 20 2017, In : Scientific Reports. 7, 42741

Research output: Contribution to journal › Article

Exosomes

Systems Biology

Oligodeoxyribonucleotides

Ligands

Neoplasms

6 Citations

Prioritization schema for immunotherapy clinical trials in glioblastoma

Hodges, T. R., Ferguson, S. D., Caruso, H. G., Kohanbash, G., Zhou, S., Cloughesy, T. F., Berger, M. S., Poste, G. H., Khasraw, M., Ba, S., Jiang, T., Mikkelson, T., Yung, W. K. A., de Groot, J. F., Fine, H., Cantley, L. C., Mellinghoff, I. K., Mitchell, D. A., Okada, H. & Heimberger, A. B., May 16 2016, (Accepted/In press) In : OncoImmunology.

Research output: Contribution to journal › Article

Glioblastoma

Immunotherapy

Clinical Trials

Hope

Therapeutics